UPDATE 3-AcelRx Pharma shares sink as FDA rejects opioid painkiller By: Reuters: Company News October 12, 2017 at 11:42 AM EDT * Shares tumble as much as 62.6 pct to $2.00 (Adds analyst comment, details from conference call; Updates bullets, shares) Read More >> Related Stocks: Acelrx Pharmaceutica Intellipharmaceutics